IP Library › Granted Patent US 10,648,109
Granted Patent B2
US 10,648,109 · App. 16/069,635 · Granted May 12, 2020

Pliable silk medical device

Inventors: Enrico Mortarino (Hickory, NC); Jessica L. Akers (Cambridge, MA); Kantilal N. Patel (Goldsboro, NC)
Assignee: Sofregen Medical Ireland Limited
D04B21/12A61F2/0059A61F2/0063A61F2/12A61L31/005A61L31/047D02G3/02D04B21/08A61F2002/0068D02G3/28D10B2211/04D10B2509/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,648,109
App. No.
16/069,635
Granted
May 12, 2020
Kind
B2
Abstract

An implantable, pliable silk device (e.g., in a form of a knitted mesh) for use in human soft tissue support and/or repair that provides stretch or pliable properties, e.g., multi-directional elongation properties. Such a device permits physicians or users to alter or manipulate the device dimension and/or shape at the time of device implantation, thereby permitting the device to conform to the contour of a target area or tissue more easily and providing more precise positioning of the device over the target area or tissue. In some embodiments, the implantable pliable silk device comprises a knit pattern feature that substantially prevents unraveling and preserves the stability of the mesh when cut. For example, the pliable silk device is a knitted mesh comprising at least two yarns laid in a knit direction and engaging each other to define a plurality of nodes.

Claims (42)

1. A process for forming a pliable silk fibroin mesh, the process comprising the steps of:

knitting a first silk fibroin yarn in a first wale direction using the knit pattern 1/1-1/3-3/3-3/1;

knitting a second silk fibroin yarn in a second wale direction using the knit pattern 3/1-1/1-1/3-3/3;

knitting a third silk fibroin yarn in a first course direction using the knit pattern 1/1-5/5-5/5-3/3-3/3-5/5-5/5-3/3-3/3-7/7-7/7-3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5-3/3; and

knitting a fourth silk fibroin yarn in a second course direction using the knit pattern 3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5-1/1-1/1-5/5-5/5-3/3-3/3-5/5-5/5-3/3-3/3-7/7-7/7-3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5,

thereby forming the pliable silk fibroin mesh.

2. The process of claim 1 , wherein the pliable silk fibroin mesh is characterized in that elongation at break along a direction of the pliable silk fibroin mesh formation is greater than 85% and elongation at break along a width of the pliable silk fibroin mesh is greater than 85%.

3. The process of claim 1 , wherein the pliable silk fibroin mesh comprises pores having an average pore area of greater than 1 mm 2 .

4. The process of claim 1 , wherein the silk fibroin yarn comprises silk fibroin fibers.

5. The process of claim 1 , wherein the silk fibroin yarn is sericin-depleted.

6. A pliable silk fibroin mesh formed by a process comprising:

knitting a first silk fibroin yarn in a first wale direction using the knit pattern 3/1-1/1-1/3-3/3;

knitting a second silk fibroin yarn in a second wale direction using the knit pattern 1/1-1/3-3/3-3/1;

knitting a third silk fibroin yarn in a first course direction using the knit pattern 3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5-1/1-1/1-5/5-5/5-3/3-3/3-5/5-5/5-3/3-3/3-7/7-7/7-3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5; and

knitting a fourth silk fibroin yarn in a second course direction using the knit pattern 1/1-5/5-5/5-3/3-3/3-5/5-5/5-3/3-3/3-7/7-7/7-3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5-3/3.

7. The pliable silk fibroin mesh of claim 6 , wherein the pliable silk fibroin mesh is characterized in that elongation at break along a direction of the pliable silk fibroin mesh formation is greater than 85% and elongation at break along a width of the pliable silk fibroin mesh is greater than 85%.

8. The pliable silk fibroin mesh of claim 6 , wherein the pliable silk fibroin mesh comprises pores having an average pore area of greater than 1 mm 2 .

9. The pliable silk fibroin mesh of claim 6 , wherein the silk fibroin yarns are made of nine filament and twisted silk fibroin fibers.

10. The pliable silk fibroin mesh of claim 6 , wherein the silk fibroin yarn is sericin-depleted.

11. An implantable device comprising a knitted network of silk fibroin yarns, wherein the knitted network is characterized in that average elongation at break along a direction of the knitted network formation is greater than 85% and average elongation at break along a width of the knitted network is greater than 85%, and wherein the average pore size of the knitted network is greater than 1 mm 2 .

12. The implantable device of claim 11 , wherein the knitted network exhibits one or more of the following characteristics:

(a) an average burst strength of about 0.3 MPa to about 1.5 MPa, or about 0.3 MPa to about 0.6 MPa;

(b) an average maximum tensile stress along the direction of the knitted network formation of about 0.2 MPa to about 0.4 MPa, or about 0.2 MPa to about 0.3 MPa;

(c) an average maximum tensile stress along the width of the knitted network of about 0.1 MPa to about 0.3 MPa, or about 0.15 MPa to about 0.2 MPa;

(d) an average tear strength along the direction of the knitted network formation of about 100 N to about 170 N or about 110 N to about 160 N;

(e) an average tear strength along the width of the knitted network of about 50 N to about 100 N or about 60 N to about 90 N;

(f) an average density of about 0.10 mg/mm 3 to about 0.15 mg/mm 3 ;

(g) an average elongation at a force of about 16 N along the direction of the knitted network formation of about 20% to about 50% or about 25% to about 40%; and

(h) an average elongation at a force of about 16 N along the width of the knitted network formation of about 20% to about 60% or about 30% to about 50%.

13. The implantable device of claim 11 , wherein the silk fibroin yarn comprises silk fibroin fibers.

14. The implantable device of claim 11 , wherein the silk fibroin yarn is sericin-depleted.

15. The implantable device of claim 11 , wherein the silk fibroin yarn is made of 9 silk fibroin fibers.

16. The implantable device of claim 11 , wherein the knitted network is formed by a process comprising at least one of the following steps:

(i) knitting a first silk fibroin yarn in a first wale direction using a knit pattern 1/1-1/3-3/3-3/1 or a portion thereof;

(ii) knitting a second silk fibroin yarn in a second wale direction using a knit pattern 3/1-1/1-1/3-3/3 or a portion thereof;

(iii) knitting a third silk fibroin yarn in a first course direction using a knit pattern 1/1-5/5-5/5-3/3-3/3-5/5-5/5-3/3-3/3-7/7-7/7-3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5-3/3 or a portion thereof; and

(iv) knitting a fourth silk fibroin yarn in a second course direction using a knit pattern 3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5-1/1-1/1-5/5-5/5-3/3-3/3-5/5-5/5-3/3-3/3-7/7-7/7-3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5 or a portion thereof.

17. The implantable device of claim 11 , wherein the knitted network is formed by a process comprising at least one of the following steps:

(i) knitting a first silk fibroin yarn in a first wale direction using a knit pattern 3/1-1/1-1/3-3/3 or a portion thereof;

(ii) knitting a second silk fibroin yarn in a second wale direction using a knit pattern 1/1-1/3-3/3-3/1 or a portion thereof;

(iii) knitting a third silk fibroin yarn in a first course direction using a knit pattern 3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5-1/1-1/1-5/5-5/5-3/3-3/3-5/5-5/5-3/3-3/3-7/7-7/7-3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5 or a portion thereof; and

(iv) knitting a fourth silk fibroin yarn in a second course direction using the knit pattern 1/1-5/5-5/5-3/3-3/3-5/5-5/5-3/3-3/3-7/7-7/7-3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5-3/3-3/3-5/5-5/5-3/3 or a portion thereof.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2020
From: MORTARINO, ENRICO
To: ALLERGAN, INC.
Reel/Frame 052272/0127 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2020
From: MORTARINO, ENRICO
To: ALLERGAN, INC.
Reel/Frame 052272/0149 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2020
From: AKERS, JESSICA L.
To: ALLERGAN, INC.
Reel/Frame 052273/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2020
From: ALLERGAN, INC.
To: SOFREGEN MEDICAL IRELAND LIMITED
Reel/Frame 052273/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2020
From: PATEL, KANTILAL N.
To: SOFREGEN MEDICAL IRELAND LIMITED
Reel/Frame 052273/0776 →
Continuity (3)
Provisional Application 62289021 · Jan 29, 2016
Provisional Application 62287386 · Jan 26, 2016
Related Publication 20190307917A1 · Oct 10, 2019
Cited By (1)
US 12,599,694